Bicara Therapeutics Inc. (BCAX)
Nasdaq: BCAX · Pharmaceutical Preparations · Boston, MA · filing with the SEC since 2024
Who runs Bicara Therapeutics Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Cohlhepp Ryan
President, COO & Interim CEO. First filing Sep 2024, latest Sep 10, 2026, 14 filings in all.
Officers reporting now
7
of 20 people with a filing in the last fifteen months
Directors reporting now
13
23 people on the record since 2024
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Cohlhepp Ryan | President, COO & Interim CEO | Sep 2024 | Sep 10, 2026 | 29 · $4.6M |
| Larson Jennifer | Chief Financial Officer | Aug 2026 | Aug 14, 2026 | none |
| Mazumdar Claire | Chief Executive Officer | Sep 2024 | Aug 12, 2026 | 17 · $4.1M |
| Hyep Ivan | Chief Financial Officer | Sep 2024 | Aug 12, 2026 | 17 · $3.2M |
| Schelman William | Chief Medical Officer | May 2026 | May 12, 2026 | none |
| Raben David | Chief Medical Officer | Sep 2024 | Apr 28, 2026 | 8 · $1.1M |
| Meisner Lara | Chief Legal Officer | Sep 2024 | Feb 4, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Bender Jeremy | director | Jul 2026 | Jul 29, 2026 | none |
| Oliger Christy J. | director | Jul 2026 | Jul 29, 2026 | none |
| Bowden Christopher | director | Sep 2024 | Jun 10, 2026 | none |
| Haviland Kate | director | Sep 2024 | Jun 10, 2026 | none |
| Kolchinsky Peter | director | Sep 2024 | Jun 10, 2026 | none |
| Mazumdar-Shaw Kiran | director | Sep 2024 | Jun 10, 2026 | none |
| Powell Michael | director | Sep 2024 | Jun 10, 2026 | none |
| Ra Capital Healthcare Fund LP | director | Sep 2024 | Jun 10, 2026 | none |
| Ra Capital Management, L.P. | director | Sep 2024 | Jun 10, 2026 | none |
| Ra Capital Nexus Fund III, L.P. | director | Sep 2024 | Jun 10, 2026 | none |
| Robertson Scott M. | director | Sep 2024 | Jun 10, 2026 | none |
| Shah Rajeev M. | director | Sep 2024 | Jun 10, 2026 | none |
| Simson Jake | director | Sep 2024 | Jun 10, 2026 | none |
Earlier names on the record16, newest filing first
Lonberg Nils · director · last filing Jun 2025Bonderman David · 10% owner · last filing Sep 2024Coulter James G · 10% owner · last filing Sep 2024Fil Ltd · 10% owner · last filing Sep 2024Fmr LLC · 10% owner · last filing Sep 2024Tpg Gp A, LLC · 10% owner · last filing Sep 2024Winkelried Jon · 10% owner · last filing Sep 2024Deerfield Private Design Fund V, L.P. · director · last filing Sep 2024Deerfield Management Company, L.P. (Series C) · 10% owner · last filing Sep 2024Deerfield Mgmt L.P. · 10% owner · last filing Sep 2024Deerfield Mgmt V, L.P. · 10% owner · last filing Sep 2024Deerfield Partners, L.P. · 10% owner · last filing Sep 2024Flynn James E · 10% owner · last filing Sep 2024Biocon Ltd · 10% owner · last filing Sep 2024Biocon Pharma Inc. · 10% owner · last filing Sep 2024Ng Carolyn · director · last filing Sep 2024
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.